GCO
Genesco Inc.
GCO's fundamentals are mixed, but it looks expensive: trading at 9.0x earnings, above its usual 7.3x. Analysts expect strong earnings growth.
GCO Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Strong |
GCO's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
GCO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6x | $23.89 | -33% |
| Fair | 7.3x | $28.93 | -19% |
| Current | 9x | $35.78 | — |
| Forward | 12x | $35.78 | — |
| Expensive | 20x | $78.41 | +119% |
Historical ranges are pointers, not guarantees.
GCO's PE is in its expensive range at 9.0x. On analysts' estimates for next year's earnings, today's price would be 12x.
GCO Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Stable | |
| Improving | |
| Limited | |
| High |
Analysts expect GCO's earnings to grow and its profitability to improve, with its revenue holding steady.
GCO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.09 | -22% |
| Q3 2026 | $3.96 | +$6.37 |
| Q2 2026 | $1.85 | +$3.38 |
| Q1 2026 | $1.25 | +$2.99 |
| Q4 2025 | -$0.15 | +$2.46 |
| Q3 2025 | -$2.41 | -$2.16 |
| Q2 2025 | -$1.53 | +$0.60 |
| Q1 2025 | -$1.74 | -$0.24 |
| Q4 2024 | -$2.61 | -$1.87 |
GCO has returned to profit: it earned $3.96 per share over the past year, after losing money the year before.
GCO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $529.9M | -3% |
| Q2 2026 | $487M | +2.8% |
| Q1 2026 | $799.9M | +7.2% |
| Q4 2025 | $616.2M | +3.3% |
| Q3 2025 | $546M | +4% |
| Q2 2025 | $474M | +3.6% |
| Q1 2025 | $745.9M | +0.9% |
| Q4 2024 | $596.3M | +2.9% |
GCO's revenue grew through 2021 and has held roughly level since: $530M last quarter, down 3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 0.7% | +3.3 points |
| Q2 2026 | -3.2% | +2.8 points |
| Q1 2026 | 6.4% | +0.2 points |
| Q4 2025 | 1.4% | -0.3 points |
| Q3 2025 | -2.6% | -0.7 points |
| Q2 2025 | -5.9% | +1.1 points |
| Q1 2025 | 6.2% | +1.1 points |
| Q4 2024 | 1.7% | -0.2 points |
GCO's operating margin was 0.7% last quarter, up 3.3 points from the same quarter a year ago.
GCO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $60M | -16% |
| Q2 2026 | -$118.2M | +$1.7M |
| Q1 2026 | $163.5M | +58% |
| Q4 2025 | -$31.5M | +$4.7M |
| Q3 2025 | $71.7M | +262% |
| Q2 2025 | -$119.9M | -$79.8M |
| Q1 2025 | $103.3M | -4.2% |
| Q4 2024 | -$36.2M | -$23.4M |
GCO still generates free cash flow, though less than at its 2026 peak: $74M over the past year.
GCO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +4.7% | +489K shares |
| 1 year | +6.1% | +623K shares |
| 3 years | -3.8% | -427K shares |
| 5 years | -25% | -3.7M shares |
| Available history | -25% | -3.6M shares |
GCO has 11M diluted shares, up 6.1% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $12.6M |
| Q1 2025 | — |
| Q4 2024 | $440,000 |
GCO hasn't bought back shares in the past year.
GCO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.4x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | -1.4x | Net Cash |
| Q4 2025 | 1.0x | Very low |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -0.5x | Net Cash |
| Q4 2024 | 1.1x | Healthy |
GCO has more cash than debt.
GCO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.6 | Neutral |
| Stochastic | 52.5 | Neutral |
GCO's weekly RSI is 52 (neutral) and its Stochastic is 53 (neutral).
GCO PE vs Consumer Cyclical Sector
| Metric | GCO | Sector median | Relative |
|---|---|---|---|
| PE | 9x | 18x | 50% below |
| PE % | 68 | 47 | 21 pts above |
GCO is trading at 9.0x earnings, a 50% discount to the Consumer Cyclical sector's median of 18x.
GCO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $36.2 | 1.1% below |
| 20 week MA | $35.6 | 0.4% above |
| 50 week MA | $32.9 | 8.9% above |
| 100 week MA | $30.9 | 16% above |
| 200 week MA | $30.6 | 17% above |
GCO's trend is up, with a small recent dip: it's below only its 8-week average, and 17% above its 200-week average.
GCO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $48.2 | $27.9 | -42% |
| 2021 | $27.9 | $59.8 | +114% |
| 2022 | $59.8 | $44.2 | -26% |
| 2023 | $44.2 | $35.2 | -20% |
| 2024 | $35.2 | $42.1 | +20% |
| 2025 | $42.1 | $25.6 | -39% |
| 2026 YTD | $25.6 | $35.8 | +40% |
GCO's yearly returns have swung widely, from +114% in 2021 to −42% in 2020. It's up 40% so far in 2026.